An Opportunity 10X Bigger Than The Presidential Debates: Twitter Inc (TWTR) Stock
/
Date20 Oct 2016
Twitter has had more success than YouTube with ‘live’ streaming the US presidential debates. The skeptics seem to be worried about ‘what after’ the presidential... Read More →
Tesla Stock: Even Strong Q3 2016 Earnings And Autopilot May Not Help Tesla Motors Inc (TSLA)
/
Date20 Oct 2016
Tesla yesterday released a hardware update to its autopilot function which is likely to improve safety. Tesla is likely to report a strong quarter on... Read More →
Tryggingamiðstöðin hf.
/
Date20 Oct 2016
TM býður til kynningarfundar á afkomu félagsins á þriðja ársfjórðungi föstudaginn 28. október kl. 8:30. Þar mun Sigurður Viðarsson forstjóri kynna uppgjörið og svara spurningum.... Read More →
Spark Therapeutics Announces Collaboration with Leading Gene Therapy Center at University of Massachusetts Medical School
/
Date20 Oct 2016
PHILADELPHIA, Oct. 20, 2016 (GLOBE NEWSWIRE) — Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company seeking to transform the lives of patients with debilitating... Read More →
AMZN Stock: Amazon.com Inc. (AMZN) Continues Its World Domination Quest
/
Date20 Oct 2016
The launch of Amazon Music Unlimited looks another masterstroke and will increase Prime memberships accordingly. The expansion of Amazon’s logistics will benefit Amazon Fresh plus brick... Read More →
Under Armour Inc: Will Q3 Earnings Open Up A Buying Opportunity In UA Stock?
/
Date20 Oct 2016
Under Armour lost nearly 25% in stock value over the past 12 months. The company still intends to keep its 20%+ growth record intact. Any... Read More →
Strong finish of the financial year
/
Date20 Oct 2016
Fourth quarter · Net sales for the quarter rose 11.0 per cent to SEK 1,952 million (1,759). · Organic growth in fixed exchange rates was... Read More →
MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial with Novel Cancer Antibody
/
Date20 Oct 2016
MARTINSRIED / MUNICH, Germany, Oct. 20, 2016 (GLOBE NEWSWIRE) — MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that it has... Read More →
Stark avslutning på verksamhetsåret
/
Date20 Oct 2016
Fjärde kvartalet · Nettoomsättningen ökade med 11,0 procent under kvartalet till 1 952 miljoner kronor (1 759). · Den organiska tillväxten i fasta växelkurser var... Read More →
RadioMedix Inc. successfully completed the Phase I/ II clinical studies for AminoMedix ™ used for radiation kidney protection during Peptide-Receptor Radionuclide Therapy (PRRT)
/
Date20 Oct 2016
Houston, TX, Oct. 20, 2016 (GLOBE NEWSWIRE) — RadioMedix Inc. (Houston,TX) is excited to announce the completion of the Phase I/II clinical trial of AminoMedix... Read More →